What medicines are available for psychedelic therapy?
There are many molecules being studied in mental health. The FDA is currently considering new drug applications for patented versions of Ketamine, MDMA, Esketamine, Psilocybin, LSD, DMT. Many of these have been noted as "Priority Review". Research into these generic compounds extends over 100 years, with early research studying the effects of mescaline in indigenous plant-medicine practitioners of the desert Southwest on the body and mind.
The experience that accompany these molecules was labeled "psychedelic" in the 1950's, which has become the umbrella term for the experience and after-effects of ingesting these compounds. Pharmaceutical companies are studying patented forms of these drug compounds to produce and sell at scale for profit. Many of these molecules are found in their whole forms in nature.
These and other plant-based or synthetic compounds may be combined in ways that may or may not elicit any associated experience.
You are not just a meat bag of chemicals. You are a meat bag of chemicals having an experience.



"Inadequate response to first- and second-line pharmacological treatments for psychiatric disorders is commonly observed. Ketamine has demonstrated efficacy in treating adults with treatment-resistant depression (TRD), with additional off-label benefits reported for various psychiatric disorders. Extant literature supports the potential use of ketamine for the treatment of PTSD, OCD, and alcohol use disorders with significant improvement of patient symptoms."



